
Generation Bio Co.
NASDAQ:GBIO
0.48 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 76.301 | 66.446 | 93.171 | 375.145 | 62.889 | 15.076 | 7.305 |
Short Term Investments
| 108.922 | 197.918 | 185.92 | 0 | 199.438 | 0 | 67.565 |
Cash and Short Term Investments
| 185.223 | 264.364 | 279.091 | 375.145 | 262.327 | 15.076 | 74.87 |
Net Receivables
| 0 | 3.96 | 0.395 | 0 | 0 | 0.448 | 1.288 |
Inventory
| 0 | -0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 7.68 | 4.294 | 7.53 | 7.411 | 10.816 | 2.632 | 0.768 |
Total Current Assets
| 192.903 | 272.618 | 287.016 | 379.186 | 267.735 | 18.156 | 76.926 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 35.603 | 95.651 | 81.423 | 91.029 | 23.781 | 21.845 | 4.486 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 5.692 | 5.692 | 2.051 | 2.052 | 2.107 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 2.691 | 6.489 | 2.133 | 0.864 | 0.588 | 0.087 | 0 |
Total Non-Current Assets
| 38.294 | 102.14 | 89.248 | 97.585 | 26.42 | 23.984 | 6.593 |
Total Assets
| 231.197 | 374.758 | 376.264 | 476.771 | 294.155 | 42.14 | 83.519 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 1.408 | 2.346 | 0.662 | 2.023 | 0.267 | 2.251 | 1.681 |
Short Term Debt
| 13.006 | 18.413 | 14.172 | 9.216 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 10.582 | 12.919 | 0 | 11.501 | 1.389 | 1.37 | 0.004 |
Other Current Liabilities
| 10.059 | 16.529 | 4.316 | 7.569 | 10.953 | 6.907 | 4.87 |
Total Current Liabilities
| 35.055 | 39.914 | 19.15 | 18.808 | 11.22 | 9.158 | 6.555 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 80.554 | 89.774 | 74.621 | 76.217 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 41.942 | 0 | 0 | 14.922 | 15.981 | 2.962 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 29.384 | 0 | 0 | 0 | 0 | 115.593 | 115.593 |
Total Non-Current Liabilities
| 109.938 | 131.716 | 74.621 | 76.217 | 14.922 | 131.574 | 118.555 |
Total Liabilities
| 144.993 | 171.63 | 93.771 | 95.025 | 26.142 | 140.732 | 125.11 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 294.155 | 115.593 | 115.593 |
Common Stock
| 0.007 | 0.007 | 0.006 | 0.006 | 0.005 | 0.001 | 0.001 |
Retained Earnings
| -703.045 | -571.377 | -444.765 | -308.126 | -188.975 | -108.452 | -47.135 |
Accumulated Other Comprehensive Income/Loss
| 0.159 | 0.274 | -0.083 | 0 | 0.009 | -115.593 | -0.009 |
Other Total Stockholders Equity
| 789.083 | 774.224 | 727.335 | 689.866 | 456.974 | 9.859 | -115.593 |
Total Shareholders Equity
| 86.204 | 203.128 | 282.493 | 381.746 | 268.013 | -98.592 | -41.591 |
Total Equity
| 86.204 | 203.128 | 282.493 | 381.746 | 268.013 | -98.592 | -41.591 |
Total Liabilities & Shareholders Equity
| 231.197 | 374.758 | 376.264 | 476.771 | 294.155 | 42.14 | 83.519 |